COMMUNIQUÉS West-GlobeNewswire

Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
05/06/2024
Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners, and HM Capital. Proceeds will support NDA submission and commercial [...]
Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
05/06/2024
Former Global Controller of Merck & Co., Inc. Enhances Financial, Operational and Strategic Transformational Expertise REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or [...]
CirrusMD Completes National Roll-out of VA Health Chat, Providing Care Access for over 6.8 Million Veterans
05/06/2024
VA Health Chat is now available to Veterans in all 18 VISNs across the U.S. DENVER, June 05, 2024 (GLOBE NEWSWIRE) -- CirrusMD, a leading provider of physician-first on-demand virtual care, today announced that VA [...]
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
05/06/2024
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]
Safety Shot Partners with Prime CSB to Expand Distribution Into New York and New Jersey
05/06/2024
The First of Its Kind Beverage Adds Two Key Markets to Distribution as Part of Its Northeast Expansion Plan JUPITER, FL, June 05, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today [...]
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
05/06/2024
DNA vaccine proof-of-concept study expected to demonstrate an “mRNA better” platform LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN ), a clinical-stage company focused on developing [...]
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
05/06/2024
FDA review of historic data shows patients who received robotic prostatectomies have overall cancer survival rates on par with open surgery SUNNYVALE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a [...]
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
05/06/2024
Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 Continuous blood glucose monitor offers the potential for simplified, discreet and less intrusive [...]
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
05/06/2024
InjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the payment of $1 million into third-party escrow account. Closing on the Asset Purchase and [...]
Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
05/06/2024
Study intended to optimize design elements needed for the upcoming US Pivotal Phase 3 studies and support ongoing partnership discussions Topline results expected in early Q4 2024 GLEN ALLEN, Va., June 05, 2024 (GLOBE [...]
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
05/06/2024
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company [...]
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
05/06/2024
Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities a vailable to patients who submit chest and abdominal CT scans for second opinions Offering the power of [...]
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts
05/06/2024
Appoints David Sutherland, CPA, as Vice President of Finance and Controller BOSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing [...]
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation
05/06/2024
Naples, FL, June 05, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp ( OTCQB: HLYK ), a leader in personalized healthcare and patient-centric services, proudly announces a $1 million financing by its CEO, Dr. [...]
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
05/06/2024
CONSHOHOCKEN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Goldman Sachs 45 th Annual Global Healthcare Conference on [...]
Clene to Present at the Emerging Growth Conference
05/06/2024
SALT LAKE CITY, June 05, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Equip’s Second Annual Report Highlights First-Rate Patient Outcomes, Company Growth
05/06/2024
Available to more than 110 million Americans of all ages, Equip’s wraparound program meets patients at every stage of treatment SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Equip , the leading provider of virtual, [...]
Bluejay Therapeutics Presents Positive Preliminary BJT-778 Data from Phase 2 Clinical Trial in Chronic Hepatitis D at EASL 2024 Congress
05/06/2024
100% of treated patients in Arm 1 achieved virologic response by Week 28 Most patients also achieved ALT normalization and composite response BJT-778 was well tolerated across all arms at doses up to 900mg SAN MATEO, [...]
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
05/06/2024
MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, and [...]

Pages